|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/517 | |
| A61K 31/519 | |||
| A61P 33/00 |
| (11) | Patento numeris | 2790705 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12818825.7 |
| Europos patento paraiškos padavimo data | 2012-12-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/057332 |
| Data | 2012-12-14 |
| (87) | Numeris | WO 2013/088404 |
| Data | 2013-06-20 |
| (30) | Numeris | Data | Šalis |
| 201161576194 P | 2011-12-15 | US |
| (72) |
COOKE, Nigel Graham, CH
FERNANDES GOMES DOS SANTOS, Paulo Antonio, CH
FURET, Pascal, CH
HEBACH, Christina, CH
HÖGENAUER, Klemens, CH
HOLLINGWORTH, Gregory, GB
KALIS, Christoph, CH
LEWIS, Ian, CH
SMITH, Alexander Baxter, CH
SOLDERMANN, Nicolas, CH
STAUFFER, Frédéric, CH
STRANG, Ross, CH
STOWASSER, Frank, CH
TUFILLI, Nicola, CH
VON MATT, Anette, CH
WOLF, Romain, CH
ZECRI, Frédéric, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K |
| USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K |